News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,188 Results
Type
Article (14282)
Company Profile (281)
Press Release (254625)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79582)
Career Advice (153)
Deals (13240)
Drug Delivery (35)
Drug Development (50475)
Employer Resources (31)
FDA (5730)
Job Trends (5140)
News (144510)
Policy (10034)
Tag
Academia (916)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21691)
ALS (69)
Alzheimer's disease (851)
Antibody-drug conjugate (ADC) (109)
Approvals (5757)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (60)
Brain cancer (20)
Breast cancer (162)
Cancer (1531)
Cardiovascular disease (121)
Career advice (134)
Career pathing (2)
CAR-T (126)
Cell therapy (346)
Cervical cancer (9)
Clinical research (41191)
Collaboration (562)
Compensation (283)
Complete response letters (13)
COVID-19 (1034)
CRISPR (44)
C-suite (173)
Cystic fibrosis (78)
Data (1630)
Denatured (11)
Depression (32)
Diabetes (142)
Diagnostics (1305)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (86)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (93)
Earnings (30198)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48865)
Executive appointments (477)
FDA (6508)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (520)
Gene editing (102)
Generative AI (10)
Gene therapy (270)
GLP-1 (373)
Government (1084)
Grass and pollen (2)
Guidances (73)
Healthcare (6602)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1101)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7286)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1386)
Liver cancer (34)
Lung cancer (208)
Lymphoma (105)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (64)
Medical device (2607)
Medtech (2608)
Mergers & acquisitions (6298)
Metabolic disorders (408)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (74)
Neuropsychiatric disorders (25)
Neuroscience (1280)
NextGen: Class of 2025 (2023)
Non-profit (854)
Now hiring (22)
Obesity (197)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (124)
Partnered (8)
Patents (137)
Patient recruitment (83)
Peanut (35)
People (25705)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14554)
Phase II (19168)
Phase III (12101)
Pipeline (983)
Policy (49)
Postmarket research (852)
Preclinical (6166)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (299)
Real estate (1419)
Recruiting (12)
Regulatory (8680)
Reports (17)
Research institute (939)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (5)
RSV (10)
Schizophrenia (64)
Series A (101)
Series B (70)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (217)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (135)
Last 7 days (618)
Last 30 days (1988)
Last 365 days (19379)
2025 (7227)
2024 (20553)
2023 (22429)
2022 (26847)
2021 (27820)
2020 (23363)
2019 (16248)
2018 (11753)
2017 (13746)
2016 (11844)
2015 (14354)
2014 (10394)
2013 (7486)
2012 (7532)
2011 (7615)
2010 (7432)
Location
Africa (148)
Alabama (44)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17372)
Australia (2947)
California (4115)
Canada (1184)
China (378)
Colorado (154)
Connecticut (156)
Delaware (110)
Europe (37376)
Florida (501)
Georgia (125)
Idaho (17)
Illinois (242)
India (10)
Indiana (94)
Iowa (2)
Japan (80)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (498)
Massachusetts (3279)
Michigan (74)
Minnesota (153)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1016)
New Mexico (12)
New York (1099)
North Carolina (572)
North Dakota (5)
Northern California (1846)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (775)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1575)
Tennessee (25)
Texas (478)
United States (14032)
Utah (56)
Virginia (85)
Washington D.C. (31)
Washington State (363)
Wisconsin (18)
269,188 Results for "jasper therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 13, 2025
·
9 min read
Press Releases
Jasper Therapeutics to Present at Upcoming March 2025 Investor Conferences
February 26, 2025
·
5 min read
Press Releases
Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
February 4, 2025
·
4 min read
Press Releases
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting
March 3, 2025
·
5 min read
Immunology and inflammation
Jasper Posts Promising Mid-Stage Data for Urticaria Drug, Eyes Challenge to Blockbusters
With positive results for patients with the chronic skin condition, Jasper Therapeutics’ briquilimab is looking to take on Novartis and Genentech’s Xolair as well as Sanofi and Regeneron’s Dupixent.
October 15, 2024
·
2 min read
·
Tristan Manalac
Biotech Bay
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper) today announced today announced that its management will present at the Oppenheimer Novel Targets in Immunology Summit, to be held on Monday, June 24, 2024, in New York City.
June 17, 2024
·
4 min read
Press Releases
Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
February 27, 2025
·
11 min read
Press Releases
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
March 3, 2025
·
9 min read
Business
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today announced the appointment of Svetlana Lucas, Ph.D., to Jasper’s Board of Directors (the Board), effective as of June 18, 2024.
June 19, 2024
·
6 min read
Press Releases
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
February 10, 2025
·
6 min read
1 of 26,919
Next
